Sponsor or institution

Clinical trials and research at LaNova Medicines Limited

• 10Clinical trials
• 3Countries

Newest trials

All recruiting trials (10)

• LM-168 with other cancer treatments in advanced solid tumors

  This trial tests LM-168 in combination with other cancer therapies to see if it is safe and tolerable and to check early signs of activity in adults with advanced solid tumors.

  Recruiting Phase 2 LaNova Medicines Limited · Beijing, Beijing Municipality · NCT07669415

• Phase II LM-24C5 treatment for CEACAM5-positive advanced solid tumors

  This trial tests whether giving LM-24C5 together with other therapies is safe and helps adults (18–80) who have CEACAM5-positive advanced solid tumors.

  Recruiting Phase 2 LaNova Medicines Limited · Fuzhou, Fujian and 1 other locations · NCT07387081

• LM-108 plus toripalimab versus paclitaxel for CCR8-positive advanced gastric or gastroesophageal junction (GEJ) adenocarcinoma

  This trial tests whether adding LM-108 (an anti-CCR8 antibody) to the PD-1 blocker toripalimab works better than paclitaxel for adults with CCR8-positive advanced or metastatic gastric or GEJ adenocarcinoma after first-line therapy.

  Recruiting Phase 3 LaNova Medicines Limited · Beijing, Beijing Municipality · NCT07362186

• LM-350 treatment for advanced solid tumors

  This trial will test LM-350, an experimental injectable drug, in adults with advanced solid tumors who have not responded to or cannot receive standard treatments.

  Recruiting at 3 sites Phase 1/2 LaNova Medicines Limited · Wollongong, New South Wales and 3 other locations · NCT07112222

• LM-168 alone or combined with toripalimab for advanced solid tumors

  This trial tests whether LM-168, given alone or together with the immunotherapy toripalimab, can shrink tumors or control disease in adults with advanced solid tumors.

  Recruiting at 5 sites Phase 1/2 LaNova Medicines Limited · Ryde, New South Wales and 5 other locations · NCT06868199

• LM-2417 for advanced solid tumors (Phase 1/2)

  This trial will test the safety and best dose of LM-2417 alone or combined with other cancer drugs in adults with advanced solid tumors who have exhausted or cannot tolerate standard therapies.

  Recruiting Phase 1/2 LaNova Medicines Limited · Shanghai, Shanghai Municipality · NCT06682780

• Testing LM-299 for advanced malignant tumors

  This study is testing a new treatment called LM-299 to see if it is safe and can help people with advanced solid tumors that haven't responded to other therapies.

  Recruiting Phase 1/2 LaNova Medicines Limited · Perth, Western Australia and 5 other locations · NCT06650566

• Testing LM-24C5 for advanced solid tumors

  This study is testing a new treatment called LM-24C5 to see if it is safe and effective for people with advanced solid tumors that haven't responded to other therapies.

  Recruiting Phase 1/2 LaNova Medicines Limited · Los Angeles, California and 5 other locations · NCT06187402

• Combining LM-302 with Toripalimab for advanced gastrointestinal cancer

  This study is testing if a new combination of two drugs, LM-302 and Toripalimab, can help people with advanced gastrointestinal cancer that has a specific marker called CLDN18.2.

  Recruiting Phase 2 LaNova Medicines Limited · Shanghai · NCT05934331

• Testing LM-101 Injection for Advanced Malignant Tumors

  This study is testing a new injection called LM-101 to see if it is safe and effective for people with advanced malignant tumors, both on its own and with other treatments.

  Recruiting at 3 sites Phase 1/2 LaNova Medicines Limited · Guangzhou, Guangdong and 4 other locations · NCT05615974

Quick answers

How many clinical trials run by LaNova Medicines Limited are recruiting right now?

10, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 3 countries. The most sites are in China (9 trials), Australia (3 trials), United States (1 trial). Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 1/2: 6, Phase 2: 3, Phase 3: 1. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →